Your browser doesn't support javascript.
loading
Plasma concentrations of advanced glycation end-products and colorectal cancer risk in the EPIC study.
Aglago, Elom K; Schalkwijk, Casper G; Freisling, Heinz; Fedirko, Veronika; Hughes, David J; Jiao, Li; Dahm, Christina C; Olsen, Anja; Tjønneland, Anne; Katzke, Verena; Johnson, Theron; Schulze, Matthias B; Aleksandrova, Krasimira; Masala, Giovanna; Sieri, Sabina; Simeon, Vittorio; Tumino, Rosario; Macciotta, Alessandra; Bueno-de-Mesquita, Bas; Skeie, Guri; Gram, Inger Torhild; Sandanger, Torkjel; Jakszyn, Paula; Sánchez, Maria-Jose; Amiano, Pilar; Colorado-Yohar, Sandra M; Gurrea, Aurelio Barricarte; Perez-Cornago, Aurora; Mayén, Ana-Lucia; Weiderpass, Elisabete; Gunter, Marc J; Heath, Alicia K; Jenab, Mazda.
Afiliação
  • Aglago EK; Nutrition and Metabolism Section, International Agency for Research on Cancer, Lyon, France.
  • Schalkwijk CG; Department of Internal Medicine, CARIM School for Cardiovascular Diseases, Maastricht University Medical Center, Maastricht, The Netherlands.
  • Freisling H; Nutrition and Metabolism Section, International Agency for Research on Cancer, Lyon, France.
  • Fedirko V; Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
  • Hughes DJ; Cancer Biology and Therapeutics Group (CBT), Conway Institute, School of Biomolecular and Biomedical Science (SBBS), University College Dublin, Dublin, Ireland.
  • Jiao L; Department of Medicine, Baylor College of Medicine, Houston, TX, USA.
  • Dahm CC; Department of Public Health, Aarhus University, Aarhus, Denmark.
  • Olsen A; Department of Public Health, Aarhus University, Aarhus, Denmark.
  • Tjønneland A; Danish Cancer Society Research Center, København, Denmark.
  • Katzke V; Danish Cancer Society Research Center, København, Denmark.
  • Johnson T; Department of Public Health, University of Copenhagen, Copenhagen, Denmark.
  • Schulze MB; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Aleksandrova K; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Masala G; Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.
  • Sieri S; Institute of Nutrition Science, University of Potsdam, Nuthetal, Germany.
  • Simeon V; Institute of Nutrition Science, University of Potsdam, Nuthetal, Germany.
  • Tumino R; Nutrition, Immunity and Metabolism Senior Scientist Group, Department of Nutrition and Gerontology, German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE), Nuthetal, Germany.
  • Macciotta A; Cancer Risk Factors and Life-Style Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network-ISPRO, Florence, Italy.
  • Bueno-de-Mesquita B; Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milano, Italy.
  • Skeie G; Dipartimento di Salute Mentale e Fisica e Medicina Preventiva, University 'Luigi Vanvitelli', Napoli, Italy.
  • Gram IT; Cancer Registry and Histopathology Department, Provincial Health Authority (ASP 7), Ragusa, Italy.
  • Sandanger T; Department of Clinical and Biological Sciences, University of Turin, Torino, Italy.
  • Jakszyn P; Department for Determinants of Chronic Diseases (DCD), National Institute for Public Health and the Environment (RIVM), PO Box 1, 3720 BA Bilthoven, The Netherlands.
  • Sánchez MJ; Faculty of Health Sciences, Department of Community Medicine, University of Tromsø, The Arctic University of Norway, Tromsø, Norway.
  • Amiano P; Faculty of Health Sciences, Department of Community Medicine, University of Tromsø, The Arctic University of Norway, Tromsø, Norway.
  • Colorado-Yohar SM; Faculty of Health Sciences, Department of Community Medicine, University of Tromsø, The Arctic University of Norway, Tromsø, Norway.
  • Gurrea AB; Unit of Nutrition and Cancer, Cancer Epidemiology Research Programme, Catalan Institute of Oncology, Barcelona, Spain.
  • Perez-Cornago A; Blanquerna School of Health Sciences, Ramon Llull University, Barcelona, Spain.
  • Mayén AL; Escuela Andaluza de Salud Pública (EASP), Granada, Spain.
  • Weiderpass E; Instituto de Investigación Biosanitaria ibs.Granada, Granada, Spain.
  • Gunter MJ; Department of Preventive Medicine and Public Health, University of Granada, Granada, Spain.
  • Heath AK; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
  • Jenab M; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Carcinogenesis ; 42(5): 705-713, 2021 05 28.
Article em En | MEDLINE | ID: mdl-33780524
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ornitina / Neoplasias Colorretais / Produtos Finais de Glicação Avançada / Lisina Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Carcinogenesis Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ornitina / Neoplasias Colorretais / Produtos Finais de Glicação Avançada / Lisina Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Carcinogenesis Ano de publicação: 2021 Tipo de documento: Article